NASDAQ · CYTHW
Healthcare · Drug Manufacturers - Specialty & Generic
$0.03
Up+$0.00 (+0.00%)
Updated Aug 15, 2026, 4:02 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
CYTHW does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning CYTHW.
CYTHW research
Company profile and research snapshot.
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Dec 17, 2020 | Maxim Group | Buy | — |
No generated briefing is available yet.
Benzinga · Mar 26, 2025
Rafael Holdings has completed its merger with Cyclo Therapeutics, a biotechnology company focused on developing treatments for Niemann-Pick Disease Type C1. The combined company will focus on advancing Cyclo's lead clinical candidate, Trappsol® Cyclo™, which is currently in a Phase 3 trial for NPC1.
Benzinga · Mar 13, 2025
Rafael Holdings reported a net loss for the second quarter and first six months of fiscal year 2025, primarily due to unrealized losses on its investment in Cyclo Therapeutics. The company is focused on Cyclo's lead clinical program Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 following the planned merger with Cyclo Therapeutics.
Benzinga · Dec 20, 2024
Halper Sadeh LLC is investigating potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders related to the proposed mergers and acquisitions of Liberty TripAdvisor Holdings, Cyclo Therapeutics, and SK Growth Opportunities Corporation.
GlobeNewswire Inc. · Dec 5, 2024
The M&A Class Action Firm is investigating the proposed mergers of Arch Resources, Universal Stainless & Alloy Products, Cyclo Therapeutics, and BurTech Acquisition Corp. The firm is encouraging shareholders to act now and provide information regarding these mergers.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CYTHW.
No results
No recent SID articles mention CYTHW.
